Literature DB >> 2580037

Gal-Gal pyelonephritis Escherichia coli pili linear immunogenic and antigenic epitopes.

M A Schmidt, P O'Hanley, G K Schoolnik.   

Abstract

The linear immunogenic and antigenic structure of E. coli Gal-Gal pili from the recombinant strain HU 849 was investigated with nine synthetic peptides corresponding to regions of the pilus sequence predicted to contain hydrophilic beta-turns. Five peptides, as bovine serum albumin conjugates, were found by anti-HU 849 pilus serum and were thus designated "immunogenic epitopes." Peptides corresponding to R 25-38, R 38-50, and R 48-61 (which jointly comprise the single intramolecular disulfide loop), and R 103-116, were bound in low titer. A prominent immunogenic epitope was specified by a peptide corresponding to R 65-75. Four peptides, as thyroglobulin conjugates, elicited antisera in rabbits that bound intact HU 849 pili. These were designated "antigenic epitopes." Two prominent antigenic epitopes were localized to peptides corresponding to R 5-12 and R 93-104, whereas peptides corresponding to R 65-75 and R 119-131 represented two minor antigenic epitopes. None of the peptide antisera bound Gal-Gal pili from heterologous strains except anti-R 93-104 and anti-R 5-12. In 8 of the 10 Gal-Gal-binding pyelonephritis isolates tested, anti-R 5-12 detected a protein with an apparent molecular weight of 18,000 co-migrating with several Gal-Gal pili. Anti-R 93-104 detected a corresponding protein in 4 of 8 fecal and 7 of 12 pyelonephritis Gal-Gal-binding isolates; however, it also bound apparently unrelated proteins of higher molecular weight.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2580037      PMCID: PMC2189064          DOI: 10.1084/jem.161.4.705

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  29 in total

1.  HOST-PARASITE INTERACTION IN PATIENTS WITH INFECTIONS DUE TO ESCHERICHIA COLI. I. THE SEROGROUPING OF E. COLI FROM INTESTINAL AND EXTRAINTESTINAL SOURCES.

Authors:  K L VOSTI; L M GOLDBERG; A S MONTO; L A RANTZ
Journal:  J Clin Invest       Date:  1964-12       Impact factor: 14.808

2.  Structural patterns in globular proteins.

Authors:  M Levitt; C Chothia
Journal:  Nature       Date:  1976-06-17       Impact factor: 49.962

Review 3.  Empirical predictions of protein conformation.

Authors:  P Y Chou; G D Fasman
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

4.  Tertiary structure in carboxypeptidase.

Authors:  I D Kuntz
Journal:  J Am Chem Soc       Date:  1972-11-29       Impact factor: 15.419

Review 5.  The structure, function, synthesis and genetic control of bacterial pili and a molecular model for DNA and RNA transport in gram negative bacteria.

Authors:  C C Brinton
Journal:  Trans N Y Acad Sci       Date:  1965-06

6.  Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides.

Authors:  E Kaiser; R L Colescott; C D Bossinger; P I Cook
Journal:  Anal Biochem       Date:  1970-04       Impact factor: 3.365

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Prediction of chain turns in globular proteins on a hydrophobic basis.

Authors:  G D Rose
Journal:  Nature       Date:  1978-04-13       Impact factor: 49.962

9.  The fimbrial and non-fimbrial haemagglutinins of Escherichia coli.

Authors:  J P Duguid; S Clegg; M I Wilson
Journal:  J Med Microbiol       Date:  1979-05       Impact factor: 2.472

10.  Interaction of human serum and neutrophils with Escherichia coli strains: differences between strains isolated from urine of patients with pyelonephritis or asymptomatic bacteriuria.

Authors:  B Björkstén; B Kaijser
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

View more
  13 in total

1.  Frequency and organization of papA homologous DNA sequences among uropathogenic digalactoside-binding Escherichia coli strains.

Authors:  K Denich; A Craiu; H Rugo; G Muralidhar; P O'Hanley
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Characterization of in vivo expression of the human papillomavirus type 16 E4 protein in cervical biopsy tissues.

Authors:  J M Palefsky; B Winkler; J P Rabanus; C Clark; S Chan; V Nizet; G K Schoolnik
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

3.  Detection of pilus subunits (pilins) and filaments by using anti-P pilin antisera.

Authors:  I E Salit; J Hanley; L Clubb; S Fanning
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

4.  Synthetic peptides corresponding to protective epitopes of Escherichia coli digalactoside-binding pilin prevent infection in a murine pyelonephritis model.

Authors:  M A Schmidt; P O'Hanley; D Lark; G K Schoolnik
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

5.  Role of the amino-terminal region of Porphyromonas gingivalis fimbriae in adherence to epithelial cells.

Authors:  H T Sojar; Y Han; N Hamada; A Sharma; R J Genco
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

6.  DNA sequences of three papA genes from uropathogenic Escherichia coli strains: evidence of structural and serological conservation.

Authors:  K Denich; L B Blyn; A Craiu; B A Braaten; J Hardy; D A Low; P D O'Hanley
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

7.  Analysis of the F antigen-specific papA alleles of extraintestinal pathogenic Escherichia coli using a novel multiplex PCR-based assay.

Authors:  J R Johnson; A L Stell; F Scheutz; T T O'Bryan; T A Russo; U B Carlino; C Fasching; J Kavle; L Van Dijk; W Gaastra
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

Review 8.  Virulence factors in Escherichia coli urinary tract infection.

Authors:  J R Johnson
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

9.  Gal-Gal pili vaccines prevent pyelonephritis by piliated Escherichia coli in a murine model. Single-component Gal-Gal pili vaccines prevent pyelonephritis by homologous and heterologous piliated E. coli strains.

Authors:  B Pecha; D Low; P O'Hanley
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

10.  Porphyromonas (Bacteroides) gingivalis fimbrillin: size, amino-terminal sequence, and antigenic heterogeneity.

Authors:  J Y Lee; H T Sojar; G S Bedi; R J Genco
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.